CCK receptor

Inhibitory Selectivity

CCK receptor Products

New CCK receptor Products
Catalog No. Information Product Use Citations Product Validations
S6939

Nastorazepide

Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor) antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF) expression in a pancreatic carcinoma orthotopic xenograft mouse.

S9690

Caerulein (FI-6934)

Caerulein (Ceruletide, Cerulein, FI-6934), a cholecystokinin (CCK) receptor agonist, is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant.

P1135New

Gastrin Tetrapeptide

Gastrin Tetrapeptide (Cholecystokinin tetrapeptide, tetragastrin, CCK-4) is the C-terminal tetrapeptide of gastrin, can stimulate gastric secretion, also is a cholecystokinin (CCK)-4 receptor agonist, with the effect of gastric mucosal protection.

Catalog No. Information Product Use Citations Product Validations
S6939

Nastorazepide

Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor) antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF) expression in a pancreatic carcinoma orthotopic xenograft mouse.

Catalog No. Information Product Use Citations Product Validations
S9690

Caerulein (FI-6934)

Caerulein (Ceruletide, Cerulein, FI-6934), a cholecystokinin (CCK) receptor agonist, is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant.

P1135New

Gastrin Tetrapeptide

Gastrin Tetrapeptide (Cholecystokinin tetrapeptide, tetragastrin, CCK-4) is the C-terminal tetrapeptide of gastrin, can stimulate gastric secretion, also is a cholecystokinin (CCK)-4 receptor agonist, with the effect of gastric mucosal protection.